Foreign Investment Screening & Foreign Subsidies in Bulgaria (2026): What Investors and Acquirers Must Know

Foreign investment screening bulgaria has moved to the centre of deal planning in 2026, as national rules interact with two powerful EU instruments, the framework for screening foreign direct investment and the Foreign Subsidies Regulation. For investors, bidders, corporate counsel and M&A teams eyeing Bulgarian targets or assets, the practical consequences are immediate: certain transactions may attract review, notification duties can arise before closing, and non-compliance carries real financial and transactional risk. This guide translates the legal framework into an actionable playbook, covering when to notify, what documents to prepare, likely outcomes and how the regimes fit together. Read on for a clear checklist of triggers, timelines, remedies and next steps for 2026 compliance.

Executive summary and AI overview of foreign investment screening bulgaria

At a glance: Foreign investors acquiring or funding Bulgarian assets in strategic sectors may need to notify authorities before completing a transaction. Two EU regimes shape the picture, Regulation (EU) 2019/452 establishing a framework for the screening of foreign direct investments into the Union, and Regulation (EU) 2022/2560 on foreign subsidies distorting the internal market (the Foreign Subsidies Regulation), which allows the European Commission to investigate financial contributions from non-EU governments that distort the internal market. National implementing measures published in Bulgaria’s State Gazette determine local triggers, and the Commission for Protection of Competition (CPC) is Bulgaria’s national competition authority. Missing a mandatory filing can delay closing, expose parties to fines and, in some cases, unwind a deal.

The top takeaways for investors are straightforward. First, identify early whether your buyer counts as a foreign investor and whether the target sits in a sector of strategic interest. Second, assess whether any non-EU government financial contribution, a “foreign subsidy”, supports the transaction. Third, map the interaction between foreign investment screening bulgaria, the EU Foreign Subsidies Regulation and merger control, because a single deal can trigger more than one regime with different authorities, thresholds and timelines. Getting this sequencing right protects your deal calendar and your certainty of completion.

Quick checklist: does your transaction trigger screening?

Before committing to a signing date, run your transaction through a short screening logic. The questions below help identify whether foreign investment screening bulgaria, the EU Foreign Subsidies Regulation or both are in play. If you answer “yes” to any category, build regulatory review into your timetable from the outset.

Transaction types that commonly attract review

• Acquisitions of control. Buying a majority stake or otherwise gaining decisive influence over a Bulgarian company.
• Minority stakes with strategic rights. Investments that confer board seats, veto rights or access to sensitive information, even below control thresholds.
• Asset deals. Purchases of critical infrastructure, land near sensitive sites, or technology assets rather than shares.
• Greenfield and capital injections. New investments and financings in strategic sectors, particularly where funded from outside the EU.
• Public procurement bids. Tenders where a bidder has received financial contributions from a non-EU state may fall within the EU Foreign Subsidies Regulation’s procurement notification track.

Sectors and red flags

Screening frameworks focus on activities where foreign control could affect security or public order. Under Regulation (EU) 2019/452, Member States may give particular attention to sensitive sectors, and investors should treat the following as high-alert areas:

• Defence and dual-use goods.
• Critical infrastructure, energy, water, transport, ports and communications.
• Telecoms and 5G networks.
• Energy generation, transmission and storage.
• Advanced technology, artificial intelligence, semiconductors, data centres and cybersecurity.
• Media, sensitive data and critical inputs.

Additional red flags include an ultimate owner controlled or subsidised by a non-EU government, funding of unclear origin, or a target holding licences, personal data or strategically important supply relationships.

Who is a “foreign investor”?

The concept of foreign investor drives most of the analysis in foreign investment screening bulgaria. Broadly, it captures investors established outside the European Union, or EU-established entities that are ultimately controlled by non-EU persons or governments. Because ownership chains are often layered, you should trace beneficial ownership to the top and identify any state-linked shareholders. A structurally EU entity can still trigger scrutiny if a non-EU parent or a foreign government stands behind it. A short decision-tree callout for your deal team is useful here: Is the investor foreign? → Does the target operate in a strategic sector? → Is a foreign subsidy involved? → Notify the competent national authority, the European Commission, or both?

Legal framework (EU + Bulgaria), how the rules interact

Understanding the legal architecture is essential because Bulgarian foreign investment rules do not operate in isolation. Three layers combine: the EU FDI screening framework, the EU Foreign Subsidies Regulation, and national implementing measures administered domestically.

The EU framework

Regulation (EU) 2019/452 establishes a framework for the screening of foreign direct investments into the Union. It does not create a single EU-wide screening authority; instead it requires cooperation and information-sharing between Member States and the European Commission and encourages Member States to maintain their own screening mechanisms. The Regulation sets out factors that may be considered, including effects on critical infrastructure, critical technologies, supply of critical inputs, access to sensitive information, and the freedom and pluralism of the media, and whether the foreign investor is controlled by a third-country government. This is the backbone against which the concept of foreign investment screening bulgaria should be read.

Note that the EU framework is under review, and investors should monitor any successor measures.

Alongside it, Regulation (EU) 2022/2560 (the Foreign Subsidies Regulation) empowers the European Commission to investigate financial contributions granted by non-EU governments to companies active in the EU where those contributions distort the internal market. It introduces notification obligations in defined situations, notably certain large concentrations and large public procurement procedures, and gives the Commission tools to investigate on its own initiative. Investors should treat foreign subsidies Bulgaria as an EU-level exposure that operates in parallel with, and not as a substitute for, national screening.

Bulgarian national law

Bulgaria’s national position is shaped by legislation and implementing acts published in the State Gazette (Darzhaven Vestnik, or DV), the official publication of Bulgarian legislation. Amendments affecting foreign investment screening and the domestic handling of foreign subsidies enter into force through publication there. Because the detail of triggers, sectors and procedural steps is set at national level and has been evolving, investors must consult the current State Gazette texts and any official guidance before assuming a transaction is out of scope.

The Commission for Protection of Competition (CPC)

The Commission for Protection of Competition is Bulgaria’s competition authority. It administers domestic merger control, enforces competition rules, and is a key national contact point for competition-related matters. Its official site sets out procedural rules, guidance and published decisions. For any deal with a Bulgarian nexus, the CPC is typically where national merger filings begin, and its decisions and public statements are a useful indicator of enforcement priorities. Investors should confirm which national body is designated to handle FDI screening under the applicable Bulgarian rules, as this may differ from the CPC.

When to notify: timing, thresholds and worked examples

Timing errors are among the most costly mistakes in cross-border deals. The safe approach to foreign investment screening bulgaria is to identify all applicable regimes at the letter-of-intent stage and reverse-engineer your timetable from the longest expected review.

National FDI notification triggers and timelines

Where a national FDI screening obligation applies, triggers typically turn on the combination of a foreign investor, a target in a strategic sector, and, in many designs, a control or influence test. Where a transaction is caught, notification is generally required before completion, and closing may be suspended pending clearance. Because the precise thresholds and deadlines are fixed by the applicable Bulgarian implementing measures and applied by the competent authority, confirm the current parameters directly against those sources rather than relying on prior deal experience.

Foreign Subsidies Regulation notification obligations

Under the EU Foreign Subsidies Regulation, notification duties arise principally in two situations: large concentrations where the parties have received sufficiently significant financial contributions from non-EU governments, and large public procurement procedures on a similar logic. In these cases the transaction or bid may not be completed or awarded until the European Commission has reviewed the foreign subsidies position. Separately, the Commission can open own-initiative investigations into other market situations. The relevant monetary thresholds for notification are set out in the Regulation and its implementing rules; confirm the current figures against the official texts. For investors, the practical message is that foreign subsidies Bulgaria exposure can exist even where national FDI screening does not apply, and vice versa.

Interaction with merger control

A transaction may simultaneously require a merger control filing, either with the CPC where national thresholds are met, or with the European Commission under the EU Merger Regulation for larger deals. The merger review, the FDI screening and the foreign subsidies assessment are legally distinct, each with its own trigger, clock and remedies toolkit. A worked example illustrates the point: a non-EU strategic investor acquiring a Bulgarian energy business that received state-backed financing from its home country might face a CPC merger filing, national FDI screening, and a Foreign Subsidies Regulation notification to the Commission, three parallel processes to sequence carefully.

Build a consolidated regulatory calendar that maps every clock against your target signing and closing dates, with buffer periods for information requests.

What information is required and how to prepare the filing

Preparation quality determines review speed. Regulators across all three regimes expect a complete, well-evidenced submission; gaps trigger information requests that stop the clock and jeopardise deadlines. Sound investor compliance Bulgaria practice starts with assembling the evidence base early.

Document list

• Transaction documents, share purchase agreement, term sheet or bid documents, and corporate resolutions.
• Ownership maps, full structure charts tracing beneficial ownership and control to the ultimate parent, flagging any state links.
• Funding origins, sources of finance, loan agreements, equity commitments and evidence of where capital originates.
• Foreign subsidy evidence, details of any financial contributions from non-EU governments or state-controlled entities to any party.
• Target activity profile, description of the target’s sector, licences, critical assets, data holdings and supply relationships.
• Mitigation proposals, draft commitments where sensitivities are anticipated.
• Confidentiality package, a redaction plan distinguishing confidential business information from the non-confidential version.

How to quantify and describe a foreign subsidy

Describing a foreign subsidy requires precision. Identify the granting non-EU authority, the form of the contribution (grant, loan, guarantee, tax advantage, capital injection or in-kind benefit), its amount and date, and its purpose. Where a contribution is contingent or ongoing, explain the mechanism and value over time. The goal is to give the reviewing authority enough to assess whether the contribution could distort competition in the internal market, under-disclosure is a far greater risk than thoroughness.

Practical drafting tips and common pitfalls

Draft the narrative for a reader unfamiliar with your business: explain the commercial rationale, the market context and why the transaction does not raise concerns. Common pitfalls include incomplete ownership disclosure, vague descriptions of funding, inconsistent figures across documents, and over-redaction that obscures the authority’s understanding. Prepare a coherent confidential and non-confidential set from the start, and keep the factual account consistent across the FDI, foreign subsidies and merger filings to avoid contradictions that invite scrutiny.

Remedies, mitigation and likely outcomes

Not every notified transaction faces obstacles, most clear, but investors should understand the range of possible outcomes and prepare mitigation in advance where sensitivities exist.

Typical remedies

Where concerns arise, authorities can accept commitments to address them. In merger and foreign subsidies practice these fall into two broad categories: structural remedies, such as divesting a business or asset, and behavioural remedies, such as commitments on conduct, access, information barriers or governance safeguards. In the foreign subsidies context, redressive measures may address the distortive effect of the contribution, for example, by requiring repayment or restricting how funds are used. The European Commission’s merger practice illustrates how structural and behavioural commitments are structured and monitored.

Negotiating commitments

Effective commitments are proportionate, clearly drafted and workable in practice. Engage the relevant authority early, understand the specific theory of harm, and tailor commitments to resolve it without giving away more than necessary. Build monitoring and, where relevant, trustee arrangements into the proposal. Because negotiating remedies takes time, factor a commitments phase into your deal calendar wherever a red flag appears in the initial screening.

Enforcement and penalties

Outcomes range from unconditional clearance, through conditional clearance with remedies, to prohibition, and, under the EU merger framework, possible referral between national and EU levels. Failing to comply with notification and standstill obligations exposes parties to significant risk: fines, and in some scenarios the voidability or unwinding of a completed transaction under the applicable national or EU regime. For penalties foreign investment Bulgaria exposure specifically, confirm the current sanction levels in the relevant Bulgarian legislation and any EU-level rules before assuming any de minimis tolerance.

Interaction with Bulgarian merger control and EU merger review

Because a single transaction can engage merger control Bulgaria foreign investors alongside FDI screening and the foreign subsidies rules, the table below sets out how the three regimes differ. Treat it as an orientation tool; confirm live thresholds and timelines against the primary sources for each deal.

Practical sequencing for multi-regime transactions

When a deal triggers several regimes, sequencing matters. Identify the longest and most uncertain process, often a foreign subsidies or FDI review with standstill effects, and anchor your timetable to it. File in parallel where the regimes are independent, keep the factual record consistent across all submissions, and align any remedies discussions so commitments offered in one process do not undercut positions in another. Coordinate with the CPC and, where relevant, the European Commission so that clearances land in a workable order relative to your signing and closing dates.

Practical timeline and deal team checklist (step-by-step)

The following step-by-step sequence turns the analysis above into an execution plan. It runs from the earliest deal stage to post-closing and is designed to protect bid deadlines and completion dates.

1. Pre-LOI / strategy. Run the screening logic: is the investor foreign, is the sector strategic, is a foreign subsidy involved? Flag all regimes potentially in play.
2. Term sheet / LOI. Build regulatory conditions and realistic long-stop dates into the transaction documents; allocate risk for clearance and standstill.
3. Diligence. Gather ownership maps, funding origins and foreign subsidy evidence in parallel with commercial due diligence.
4. Pre-notification engagement. Where appropriate, engage the relevant national authority and, for foreign subsidies cases, the European Commission to scope the filing and anticipated issues.
5. Filing. Submit complete, consistent notifications across FDI, foreign subsidies and merger control as applicable, with confidential and non-confidential versions ready.
6. Review phase. Respond promptly to information requests to avoid stopping the clock; monitor parallel timelines against your calendar.
7. Remedies (if needed). Negotiate proportionate commitments; align them across regimes.
8. Clearance and closing. Complete only once standstill obligations are satisfied and clearances are in hand.
9. Post-closing. Implement any commitments, maintain compliance records, and observe monitoring or reporting obligations.

Add buffer periods before any binding bid deadline. Because information requests can extend review, disciplined document preparation is the single best protection for your deal timetable and a cornerstone of investor compliance Bulgaria.

Next steps: making foreign investment screening bulgaria work for your deal

Foreign investment screening bulgaria in 2026 rewards early, structured planning. The safest path is to run the screening logic at the strategy stage, assemble ownership and funding evidence during diligence, and build a consolidated regulatory calendar that accounts for national FDI screening, the EU Foreign Subsidies Regulation and merger control together. Where sensitivities appear, prepare proportionate remedies in advance and engage the relevant authorities constructively. Handled well, regulatory review becomes a manageable workstream rather than a threat to your closing date, and thorough preparation is the surest protection for both deal certainty and long-term compliance.

Because the national rules in this area continue to develop, always verify current triggers, thresholds and competent authorities against the official Bulgarian sources and the relevant EU texts before relying on them for a specific transaction.

Sources

1. European Commission, Foreign Subsidies Regulation (policy & guidance)
2. EUR-Lex, Regulation (EU) 2019/452 (Framework for FDI screening)
3. EUR-Lex, Regulation (EU) 2022/2560 (Foreign Subsidies Regulation)
4. Commission for Protection of Competition (Bulgaria), official site
5. State Gazette (DV), Bulgarian official publication portal
6. European Commission, Merger control (EU Merger Regulation & guidance)